Roubaix Capital, LLC Codexis, Inc. Transaction History

Roubaix Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$25.61 - $41.78 $1.81 Million - $2.95 Million	-70,563 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$19.65 - $27.99 $1.39 Million - $1.98 Million	70,563 New	70,563 $1.64 Million
Q1 2021 Apr 29, 2021	SELL	$18.08 - $28.8 $2.94 Million - $4.68 Million	-162,619 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$11.7 - $23.41 $415,478 - $831,312	-35,511 Reduced 17.92%	162,619 $3.55 Million
Q3 2020 Nov 03, 2020	BUY	$11.21 - $13.82 $968,185 - $1.19 Million	86,368 Added 77.28%	198,130 $2.33 Million
Q2 2020 Jul 28, 2020	BUY	$9.8 - $12.77 $19,796 - $25,795	2,020 Added 1.84%	111,762 $1.27 Million
Q1 2020 Apr 15, 2020	SELL	$8.78 - $18.6 $36,717 - $77,785	-4,182 Reduced 3.67%	109,742 $1.23 Million
Q4 2019 Jan 15, 2020	BUY	$13.12 - $17.06 $4,946 - $6,431	377 Added 0.33%	113,924 $1.82 Million
Q3 2019 Oct 08, 2019	BUY	$12.75 - $19.01 $1.45 Million - $2.16 Million	113,547 New	113,547 $1.56 Million

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $327M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Roubaix Capital, LLC with notifications on news.